- Home
- ZLAB vs EYE Comparison
ZLAB vs EYE Comparison
Compare ZLAB & EYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZLAB | EYE |
|---|---|---|
| Founded | 2013 | 1990 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 2017 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ZLAB | EYE |
|---|---|---|
| Price | $18.31 | $21.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $49.60 | $31.22 |
| AVG Volume (30 Days) | 714.0K | ★ 1.7M |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.46 | ★ 202.78 |
| EPS | N/A | ★ 0.38 |
| Revenue | $460,156,000.00 | ★ $1,987,488,000.00 |
| Revenue This Year | $9.75 | $5.56 |
| Revenue Next Year | $26.03 | $6.58 |
| P/E Ratio | ★ N/A | $57.18 |
| Revenue Growth | ★ 15.33 | 9.00 |
| 52 Week Low | $15.96 | $14.75 |
| 52 Week High | $39.64 | $30.02 |
Technical Indicators
Market Signals| Indicator | ZLAB | EYE |
|---|---|---|
| Relative Strength Index (RSI) | 39.86 | 65.56 |
| Support Level | $16.84 | $18.98 |
| Resistance Level | $19.55 | $21.52 |
| Average True Range (ATR) | 0.76 | 0.90 |
| MACD | -0.25 | 0.11 |
| Stochastic Oscillator | 4.64 | 86.46 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
About EYE National Vision Holdings Inc.
National Vision Holdings Inc. is an optical retailer in the United States. Its product portfolio includes eyeglasses, sunglasses, contact lenses, accessories, and other related products. The company operates through a single operating segment. The Owned and Host segment includes the company-owned brands America's Best and Eyeglass World. In America's Best stores, vision care services are provided by optometrists or by independent professional corporations. The Host segment consists of Military and Fred Meyer locations, where eye exams are provided by independent optometrists.